SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-20-000071
Filing Date
2020-05-11
Accepted
2020-05-08 21:32:36
Documents
101
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2020033110qdoc.htm 10-Q 1641240
2 2020 ANNUAL BONUS PLAN pdli-2020033110qex102.htm EX-10.2 10761
3 CERTIFICATION pdli-2020033110qex311.htm EX-31.1 10942
4 CERTIFICATION pdli-2020033110qex312.htm EX-31.2 11259
5 CERTIFICATION pdli-2020033110qex321.htm EX-32.1 14399
12 pdllogoa31.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000071.txt   11037885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20200331.xml EX-101.INS 1954592
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20200331.xsd EX-101.SCH 119423
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20200331_cal.xml EX-101.CAL 129210
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20200331_def.xml EX-101.DEF 815815
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20200331_lab.xml EX-101.LAB 1223680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20200331_pre.xml EX-101.PRE 984269
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 20862377
SIC: 2836 Biological Products, (No Diagnostic Substances)